153 related articles for article (PubMed ID: 25755695)
1. In vitro effects of platinum compounds on renal cellular respiration in mice.
Almarzooqi SS; Alfazari AS; Abdul-Kader HM; Saraswathiamma D; Albawardi AS; Souid AK
Int J Clin Exp Pathol; 2015; 8(1):81-95. PubMed ID: 25755695
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cytotoxicities of platinum compounds.
Goodisman J; Hagrman D; Tacka KA; Souid AK
Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxicity of platinum complexes is related to basolateral organic cation transport.
Ludwig T; Riethmüller C; Gekle M; Schwerdt G; Oberleithner H
Kidney Int; 2004 Jul; 66(1):196-202. PubMed ID: 15200426
[TBL] [Abstract][Full Text] [Related]
4. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
5. Experimental study of renal disorder caused by oxaliplatin in rat renal cortical slices.
Kanou T; Uozumi J; Soejima K; Tokuda Y; Masaki Z
Clin Exp Nephrol; 2004 Dec; 8(4):310-5. PubMed ID: 15619029
[TBL] [Abstract][Full Text] [Related]
6. Platinum-induced kidney damage: Unraveling the DNA damage response (DDR) of renal tubular epithelial and glomerular endothelial cells following platinum injury.
Krüger K; Thomale J; Stojanović N; Osmak M; Henninger C; Bormann S; Fritz G
Biochim Biophys Acta; 2015 Mar; 1853(3):685-98. PubMed ID: 25565603
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants of the cytotoxicity of platinum compounds: the contribution of in silico research.
Vekris A; Meynard D; Haaz MC; Bayssas M; Bonnet J; Robert J
Cancer Res; 2004 Jan; 64(1):356-62. PubMed ID: 14729645
[TBL] [Abstract][Full Text] [Related]
8. In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance.
Haj-Yehia AI; Benet LZ
J Pharmacol Exp Ther; 1996 Sep; 278(3):1296-305. PubMed ID: 8819515
[TBL] [Abstract][Full Text] [Related]
9. The mTOR inhibitor sirolimus suppresses renal, hepatic, and cardiac tissue cellular respiration.
Albawardi A; Almarzooqi S; Saraswathiamma D; Abdul-Kader HM; Souid AK; Alfazari AS
Int J Clin Exp Pathol; 2015; 8(3):2955-62. PubMed ID: 26045804
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of thioredoxin reductase 1 correlates with platinum-based chemotherapeutic induced tissue injury.
Cheng P; Liu H; Li Y; Pi P; Jiang Y; Zang S; Li X; Fu A; Ren X; Xu J; Holmgren A; Lu J
Biochem Pharmacol; 2020 May; 175():113873. PubMed ID: 32092292
[TBL] [Abstract][Full Text] [Related]
11. Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches.
Screnci D; McKeage MJ
J Inorg Biochem; 1999 Oct; 77(1-2):105-10. PubMed ID: 10626361
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
13. Platinum-based chemotherapy induces demyelination of Schwann cells in oral squamous cell carcinoma treatment.
Wang X; Yang W; Wang L; Zheng L; Choi WS
Toxicol Appl Pharmacol; 2023 Dec; 481():116751. PubMed ID: 37944569
[TBL] [Abstract][Full Text] [Related]
14. Quantitative measure of cytotoxicity of anticancer drugs and other agents.
Tao Z; Jones E; Goodisman J; Souid AK
Anal Biochem; 2008 Oct; 381(1):43-52. PubMed ID: 18602881
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs.
Sadowitz PD; Hubbard BA; Dabrowiak JC; Goodisman J; Tacka KA; Aktas MK; Cunningham MJ; Dubowy RL; Souid AK
Drug Metab Dispos; 2002 Feb; 30(2):183-90. PubMed ID: 11792689
[TBL] [Abstract][Full Text] [Related]
16. Platinum complex toxicity in cultured renal epithelia.
Ludwig T; Oberleithner H
Cell Physiol Biochem; 2004; 14(4-6):431-40. PubMed ID: 15319547
[TBL] [Abstract][Full Text] [Related]
17. Platinum compounds in the treatment of advanced breast cancer.
Martín M
Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
[TBL] [Abstract][Full Text] [Related]
18. TCEP-based rSDS-PAGE AND nLC-ESI-LTQ-MS/MS for oxaliplatin metalloproteomic analysis.
Mena ML; Moreno-Gordaliza E; Gómez-Gómez MM
Talanta; 2013 Nov; 116():581-92. PubMed ID: 24148449
[TBL] [Abstract][Full Text] [Related]
19. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
[TBL] [Abstract][Full Text] [Related]
20. Differential toxicity of cisplatin, carboplatin, and CI-973 correlates with cellular platinum levels in rat renal cortical slices.
Leibbrandt ME; Wolfgang GH
Toxicol Appl Pharmacol; 1995 Jun; 132(2):245-52. PubMed ID: 7785052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
